@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_head { this: np:hasAssertion dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_assertion; np:hasProvenance dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_provenance; np:hasPublicationInfo dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_publicationInfo; a np:Nanopublication . dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_assertion a np:Assertion . dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_provenance a np:Provenance . dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_publicationInfo a np:PublicationInfo . } dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_assertion { miriam-gene:348 a ncit:C16612 . lld:C0153690 a ncit:C7057 . dgn-gda:DGNca9561f0514c2ed44d2a02b540f40c2a sio:SIO_000628 miriam-gene:348, lld:C0153690; a sio:SIO_001121 . } dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_provenance { dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_assertion dcterms:description "[Whereas the latter group of tumors expressed some proapoptotic genes, tumors with high FAS levels overexpressed, among other genes, its transcriptional regulator, steroid regulator binding protein, and apolipoprotein E. These data demonstrate (1) the consistent overexpression of FAS in prostate carcinoma compared with the adjacent normal tissue, (2) a strong association between FAS and prostate tumor initiation and progression, (3) the highest FAS expression occurring in androgen-independent bone metastases, (4) the transcriptional and posttranscriptional regulation of FAS in the majority and in a subset of prostate cancers, respectively, and (5) most importantly, the identification by FAS expression of prostate tumors with unique molecular signatures and potentially diverse biologic behavior.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:12939396; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP229940.RATGUgMhS0m5nDQCFX0RkY0ZEOV870vRrWfycsTrfGCV8130_publicationInfo { this: dcterms:created "2014-10-02T12:34:09+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }